In addition to Abs that directly target NK cell receptors, NK cell activity can be modulated through indirect immune-based mechanisms by some Abs which target receptors in tumor cells associated with anti-apoptotic and proliferative signaling pathways. This evidence concerns the gene DDX41 and neoplasm.